Skip to main content
Premium Trial:

Request an Annual Quote

Extra Spending Money Always Goes for Something Useful, Right?

At Eye on DNA, Hsien-Hsien Lei wonders whether the potential market for genetic services will suffer in the current economic downturn. While Americans have less and less disposable income, will they actually choose to spend money on these tests? Though direct-to-consumer genetic testing is more widely available in the U.S. than in any other country, writes Lei, "it would be interesting to see the uptake of personal genomic services in countries other than the U.S." where socialized medicine is more prevalent.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.